Birgit C. Schultes

Insider Reports History

Entity
Individual
Location
C/O Intellia Therapeutics, Inc., 40 Erie Street, Suite 130, Cambridge, MA
Signature
James Basta, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Birgit C. Schultes:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Intellia Therapeutics, Inc. EVP, Chief Scientific Officer Common Stock 105K $946K $8.99 Mar 1, 2025 Direct
Intellia Therapeutics, Inc. EVP, Chief Scientific Officer Stock Option (right to buy) 53.7K Mar 1, 2025 Direct

Insider Reports Filed by Birgit C. Schultes

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NTLA Intellia Therapeutics, Inc. Mar 1, 2025 2 $0 4 Mar 4, 2025 EVP, Chief Scientific Officer
NTLA Intellia Therapeutics, Inc. Jan 13, 2025 0 $0 3 Jan 23, 2025 EVP, Chief Scientific Officer